NAD+: Where the Science Is Solid and Where the Delivery Argument Falls Apart
NAD+ is not a peptide, but it sits in nearly every peptide catalogue we index — so it belongs in this library. The biology is well established; the product claims often are not.
500mg
Typical vial
$49
Lowest tracked
$78
Median price
121
Vendors listing
The underlying biology is not in dispute
NAD+ is a coenzyme central to redox reactions and to sirtuin and PARP activity. Around 210 studies in our index touch it. What is contested is whether administering NAD+ directly is the best way to raise cellular levels.
The precursor argument
Much of the human research investment has gone into precursors such as NR and NMN rather than NAD+ itself, on the basis that the intact molecule is poorly taken up by cells.
Vendors rarely acknowledge this debate. We grade the evidence Emerging for that reason: strong background science, unsettled delivery question.
Stability and handling
NAD+ degrades faster than most compounds in this index, particularly in solution and at room temperature. Cold-chain claims and reconstitution guidance are more meaningful signals here than elsewhere.
Pricing
500mg vials typically run £39 to £62. Per-milligram cost is low, but shipping and storage requirements affect real cost more than the sticker price does.
Frequently asked
Is NAD+ a peptide?
No, it is a coenzyme. It is included here because it appears throughout the same supplier catalogues.
NAD+ or a precursor?
The research community has not settled this. Treat confident vendor claims either way with caution.
Search focus for this profile
nad+ injection — 3,600/mo searches, difficulty 22/100 — easy. Source: Semrush (UK database).
Supporting terms covered: nad+ review, nad+ vs nmn, nad+ stability testing.
Everything below describes published research and market data. Nothing here is medical advice, and none of these compounds are sold or supplied by CheckALab.
More in Longevity
Epitalon
Tetrapeptide investigated in small telomerase and circadian studies, largely single-group.
Pinealon
Short synthetic tripeptide from the Khavinson bioregulator series, studied in Russian-language neuroprotection work.
FOXO4-DRI
Senolytic peptide studied for selectively clearing senescent cells in animal models.
SS-31
Mitochondria-targeted tetrapeptide, also known as elamipretide, with clinical trial data.
Humanin
Mitochondrial-derived peptide studied in cytoprotection and metabolic ageing research.
Cardiogen
Cardiac-tissue bioregulator peptide from the Khavinson series.